Filtered By:
Therapy: Statin Therapy
This page shows you your search results in order of date. This is page number 10.
Order by Relevance | Date
Total 407 results found since Jan 2013.
Acute and Chronic Cardiovascular Manifestations of COVID-19: Role for Endotheliopathy
Methodist Debakey Cardiovasc J. 2021 Dec 15;17(5):53-62. doi: 10.14797/mdcvj.1044. eCollection 2021.ABSTRACTSARS-CoV-2, the virus that causes coronavirus disease 19 (COVID-19), is associated with a bewildering array of cardiovascular manifestations, including myocardial infarction and stroke, myocarditis and heart failure, atrial and ventricular arrhythmias, venous thromboembolism, and microvascular disease. Accumulating evidence indicates that a profound disturbance of endothelial homeostasis contributes to these conditions. Furthermore, the pulmonary infiltration and edema, and later pulmonary fibrosis, in patients with ...
Source: Methodist DeBakey Cardiovascular Journal - January 7, 2022 Category: Cardiology Authors: John P Cooke John H Connor Abhishek Jain Source Type: research
Metainflammation in COVID-19
Endocr Metab Immune Disord Drug Targets. 2022 Jan 4. doi: 10.2174/1871530322666220104103325. Online ahead of print.ABSTRACTA new coronavirus pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2], has been on the rise. This virus is fatal for broad groups of populations, including elderly, men, and patients with comorbidities among which obesity is a possible risk factor. The pathophysiologic connections between obesity/metainflammation and COVID-19 may be directly related to increasing soluble ACE2 (angiotensin-converting enzyme 2] levels which potentiates the viral entrance into the host cells, ...
Source: Endocrine, Metabolic and Immune Disorders Drug Targets - January 5, 2022 Category: Drugs & Pharmacology Authors: Mojtaba Bakhtiari Kamyar Asadipooya Source Type: research
